- STAT+: Glenmark to pay $29.6 million to settle price-fixing allegations in long-running battle with statesGlenmark Pharmaceuticals agreed to pay $29.6 million to settle price-fixing allegations in a long-running battle with dozens of states.STAT · 13d ago↗ source
- Celcuity gains FDA approval for closely watched breast cancer drugStill, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.BioPharma Dive · 13d ago↗ source
- STAT+: In a major policy shift, Medicare proposes to ban vendors from providing remote monitoring servicesMedicare is proposing to ban vendors from providing remote patient monitoring services on behalf of doctors.